Viewing data from:

PENCICLOVIR

ANDA

PENCICLOVIR | A212368 | PADAGIS ISRAEL PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: DENAVIR(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$52.23

per gm

Lowest NADAC/Unit

$52.23

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
45802044075PENCICLOVIR 1% CREAM	$52.23	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs1 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

SMS PHARMACEUTICALS LTDPENCICLOVIR

DMF 297242015

ZHEJIANG CHARIOTEER PHARMACEUTICAL CO LTDPENCICLOVIR (API)

DMF 307582016

CHEMWERTH INCPENCICLOVIR

DMF 332602018

API PHARMA TECH LLCPENCICLOVIR

DMF 345142020

ALEMBIC PHARMACEUTICALS LTDPENCICLOVIR

DMF 350322020

MAITHRI DRUGS PRIVATE LTDPENCICLOVIR

DMF 352432020

TORRENT PHARMACEUTICALS LTDPENCICLOVIR

DMF 364102021

MYLAN LABORATORIES LTDInactivePENCICLOVIR

DMF 343752019

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1%

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: Sep 27, 2024

No patent or exclusivity listings for this strength.